NCT/UCC Imaging Platform

Precise disease staging and definition of volumes to treat is of utmost importance of anti-cancer therapy with both curative and palliative intent. In routine clinical practice, time on high-end imaging machines is scarce. Therefore, the NCT/UCC Imaging Plattform has the aim to perform high quality anatomical and functional imaging within clinical trials or prospective registries, both for staging of primary or recurrent disease, and for response monitoring following surgery, radiotherapy, systemic therapy, or a combination of those.

• Primary staging of rare tumors
• Staging of recurrent disease following primary treatment
• Longitudinal studies during treatment serving as response monitoring

• PET using tracers from University Hospital Carl Gustav Carus Dresden and from Helmholtz-Zentrum Dresden-Rossendorf
• Anatomical and functional MRI
• (Interventional dual-energy) CT
• 3-dimensional ultrasound